Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9NR9
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $38,575
Award facts
- Contract value 100% obligated
- $38,574.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $38,574.88 to AmerSourceBergen Drug Corp for the supply of Zepbound 10 mg/0.5 ml pens on January 30, 2026, with an ultimate completion date of February 2, 2026. This non-set-aside, firm fixed-price contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at up to $999,999,999.00 through December 2031 that supports military healthcare programs globally.
Zepbound, a GLP-1 receptor agonist used for weight management, falls within the broader portfolio of specialty medications that Cencora delivers to federal healthcare systems. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare procurement, AmerSourceBergen maintains extensive capability to fulfill federal medical supply requirements across multiple therapeutic domains. The contractor's significant presence within the DLA's pharmaceutical supply chain, evidenced by its substantial prime indefinite delivery contract, demonstrates its established capacity to meet the government's ongoing needs for specialty pharmaceutical products required by military treatment facilities and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F9NR9?
SPE2DR26F9NR9 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 30, 2026.
How much is contract SPE2DR26F9NR9 worth?
The government has obligated $38,575 on SPE2DR26F9NR9.
Is contract SPE2DR26F9NR9 an order under another contract?
Yes. SPE2DR26F9NR9 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9NR9 competed?
The extent of competition for SPE2DR26F9NR9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award